Early and Late Prognosis in Patients With Guillain-Barre Syndrome
NCT ID: NCT06041451
Last Updated: 2023-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
450 participants
INTERVENTIONAL
2013-01-02
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome
NCT04927598
Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
NCT02342184
Predictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré Syndrome
NCT06200454
Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome
NCT04829526
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
NCT04053452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
immunoglobulin group
This group of patients was treated with intravenous immunoglobulin(30g ivgtt qd) for 5 days
Intravenous Immunoglobulins, Human
patients were treated with intravenous immunoglobulin(30g ivgtt qd) for 5 days
methylprednisolone group
This group of patients was treated with methylprednisolone 500 MG Injection
Methylprednisolone 500 MG Injection
patients were treated with methylprednisolone
control group
This group of patients was treated without immunoglobulin or hormone
No interventions assigned to this group
mixed group
This group of patients was treated both with intravenous immunoglobulin and methylprednisolone.
Intravenous Immunoglobulins, Human
patients were treated with intravenous immunoglobulin(30g ivgtt qd) for 5 days
Methylprednisolone 500 MG Injection
patients were treated with methylprednisolone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intravenous Immunoglobulins, Human
patients were treated with intravenous immunoglobulin(30g ivgtt qd) for 5 days
Methylprednisolone 500 MG Injection
patients were treated with methylprednisolone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital of Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dengbinbin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.